Looking at CER from the Pharmaceutical Industry Perspective

por Dubois, Robert W.
Publicado 2012

Stakeholders find that step therapy should be evidence-based, flexible, and transparent: assessing appropriateness using a consensus approach

por Karmarkar, Taruja, Dubois, Robert W, Graff, Jennifer S
Publicado 2021

Review of Eight Pharmacoeconomic Studies of the Value of Biologic DMARDs Adalimumab, Etanercept, and Infliximab) in the Management of Rheumatoid Arthritis

por Doan, Quan V., Chiou, Chiun-Fang, Dubois, Robert W.
Publicado 2006

The GRACE Checklist for Rating the Quality of Observational Studies of Comparative Effectiveness: A Tale of Hope and Caution

por Dreyer, Nancy A., Velentgas, Priscilla, Westrich, Kimberly, Dubois, Robert
Publicado 2014

Economic Burden of Anemia in an Insured Population

por Nissenson, Allen R., Wade, Sally, Goodnough, Tim, Knight, Kevin, Dubois, Robert W.
Publicado 2005

Three Perspectives on the Impact of Comparative Effectiveness Research on Decision Making

por Brixner, Diana I., Oderda, Gary, Mohr, Penny, Dubois, Robert W., Cannon, H. Eric
Publicado 2012

Do Patient Preferences Align With Value Frameworks? A Discrete-Choice Experiment of Patients With Breast Cancer

por Hollin, Ilene L., González, Juan Marcos, Buelt, Lisabeth, Ciarametaro, Michael, Dubois, Robert W.
Publicado 2020

Using an Electronic Medication Refill System to Improve Provider Productivity in an Accountable Care Setting

por Schoenhaus, Robert, Lustig, Adam, Rivas, Silvia, Monrreal, Victor, Westrich, Kimberly D., Dubois, Robert W.
Publicado 2016

What Contributes Most to High Health Care Costs? Health Care Spending in High Resource Patients

por Pritchard, Daryl, Petrilla, Allison, Hallinan, Shawn, Taylor, Donald H., Schabert, Vernon F., Dubois, Robert W.
Publicado 2016

The Central Role of Physician Leadership for Driving Change in Value-Based Care Environments

por Lustig, Adam, Ogden, Michael, Brenner, Robert W., Penso, Jerry, Westrich, Kimberly D., Dubois, Robert W.
Publicado 2016

Best Practices: Improving Patient Outcomes and Costs in an ACO Through Comprehensive Medication Therapy Management

por Brummel, Amanda, Lustig, Adam, Westrich, Kimberly, Evans, Michael A., Plank, Gary S., Penso, Jerry, Dubois, Robert W.
Publicado 2014

Are ACOs Ready to be Accountable for Medication Use?

por Dubois, Robert W., Feldman, Marv, Lustig, Adam, Kotzbauer, Greg, Penso, Jerry, Pope, Scott D., Westrich, Kimberly D.
Publicado 2020

Are ACOs Ready to be Accountable for Medication Use?

por Dubois, Robert W., Feldman, Marv, Lustig, Adam, Kotzbauer, Greg, Penso, Jerry, Pope, Scott D., Westrich, Kimberly D.
Publicado 2014

No improvement in the reporting of clinical trial subgroup effects in high-impact general medical journals

por Gabler, Nicole B., Duan, Naihua, Raneses, Eli, Suttner, Leah, Ciarametaro, Michael, Cooney, Elizabeth, Dubois, Robert W., Halpern, Scott D., Kravitz, Richard L.
Publicado 2016

Evaluation of person-level heterogeneity of treatment effects in published multiperson N-of-1 studies: systematic review and reanalysis

por Raman, Gowri, Balk, Ethan M, Lai, Lana, Shi, Jennifer, Chan, Jeffrey, Lutz, Jennifer S, Dubois, Robert W, Kravitz, Richard L, Kent, David M
Publicado 2018

A Clinically Detailed Risk Information System for Cost

por Carter, Grace M., Bell, Robert M., Dubois, Robert W., Goldberg, George A., Keeler, Emmett B., McAlearney, John S., Post, Edward P., Rumpel, J. David
Publicado 2000